Comparison of dynamic susceptibility contrast MRI with conventional MRI in evaluating tumor response following bevacizumab therapy in recurrent high-grade gliomas

被引：0
|
作者：
Shah, P. N. [1 ]
Kumar, V. A. [1 ]
Jung, E. [1 ]
Knopp, E. A. [1 ]
Babb, J. S. [1 ]
Johnson, G. [1 ]
Gruber, M. L. [1 ]
Zagzag, D. [1 ]
Raza, S. [1 ]
Narayana, A. [1 ]
机构：
[1] NYU, Med Ctr, New York, NY 10016 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.2085
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2085
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Early Biomarkers from Conventional and Delayed-Contrast MRI to Predict the Response to Bevacizumab in Recurrent High-Grade Gliomas
    Daniels, D.
    Guez, D.
    Last, D.
    Hoffmann, C.
    Nass, D.
    Talianski, A.
    Tsarfaty, G.
    Salomon, S.
    Kanner, A. A.
    Blumenthal, D. T.
    Bokstein, F.
    Harnof, S.
    Yekutieli, D.
    Zamir, S.
    Cohen, Z. R.
    Zach, L.
    Mardor, Y.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2016, 37 (11) : 2003 - 2009
  • [2] EARLY BIOMARKERS FROM CONVENTIONAL MRI AND TRAMS FOR PREDICTING RESPONSE TO BEVACIZUMAB IN RECURRENT HIGH-GRADE GLIOMAS
    Daniels, D.
    Guez, D.
    Last, D.
    Talianski, A.
    Kanner, A. A.
    Blumenthal, D. T.
    Bokstein, F.
    Cohen, Z. R.
    Mardor, Y.
    Zach, L.
    NEURO-ONCOLOGY, 2016, 18 : 31 - 31
  • [3] Diffusion tensor and dynamic susceptibility contrast MRI for the assessment of high-grade gliomas
    Ntoulia, A.
    Goussia, A.
    Zikou, A.
    Alexiou, G.
    Kosta, P.
    Lampri, E.
    Astrakas, L.
    Voulgaris, S.
    Kyritsis, A.
    Argyropoulou, M.
    Malamou-Mitsi, V.
    VIRCHOWS ARCHIV, 2011, 459 : S271 - S271
  • [4] Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas
    Boxerman, Jerrold L.
    Quarles, Chad C.
    Hu, Leland S.
    Erickson, Bradley J.
    Gerstner, Elizabeth R.
    Smits, Marion
    Kaufmann, Timothy J.
    Barboriak, Daniel P.
    Huang, Raymond H.
    Wick, Wolfgang
    Weller, Michael
    Galanis, Evanthia
    Kalpathy-Cramer, Jayashree
    Shankar, Lalitha
    Jacobs, Paula
    Chung, Caroline
    van den Bent, Martin J.
    Chang, Susan
    Al Yung, W. K.
    Cloughesy, Timothy F.
    Wen, Patrick Y.
    Gilbert, Mark R.
    Rosen, Bruce R.
    Ellingson, Benjamin M.
    Schmainda, Kathleen M.
    NEURO-ONCOLOGY, 2020, 22 (09) : 1262 - 1275
  • [5] DYNAMIC SUSCEPTIBILITY CONTRAST PERFUSION MRI IN DIFFERENTIATING RADIATION NECROSIS FROM TUMOR RECURRENCE IN HIGH-GRADE GLIOMAS
    Pica, A.
    Hauf, M.
    Slotboom, J.
    Beck, J.
    Schucht, P.
    Aebersold, D. M.
    Wiest, R.
    NEURO-ONCOLOGY, 2012, 14 : 35 - 36
  • [6] Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma
    Schmainda, Kathleen M.
    Prah, Melissa
    Connelly, Jennifer
    Rand, Scott D.
    Hoffman, Raymond G.
    Mueller, Wade
    Malkin, Mark G.
    NEURO-ONCOLOGY, 2014, 16 (06) : 880 - 888
  • [7] Preoperative vascular heterogeneity based on dynamic susceptibility contrast MRI in predicting spatial pattern of locally recurrent high-grade gliomas
    Hanwei Wang
    Linlan Zeng
    Hao Wu
    Jing Tian
    Huan Xie
    Letian Zhang
    Qisheng Ran
    Peng Zhong
    Lizhao Chen
    Liang Yi
    Shunan Wang
    European Radiology, 2024, 34 : 1982 - 1993
  • [8] Preoperative vascular heterogeneity based on dynamic susceptibility contrast MRI in predicting spatial pattern of locally recurrent high-grade gliomas
    Wang, Hanwei
    Zeng, Linlan
    Wu, Hao
    Tian, Jing
    Xie, Huan
    Zhang, Letian
    Ran, Qisheng
    Zhong, Peng
    Chen, Lizhao
    Yi, Liang
    Wang, Shunan
    EUROPEAN RADIOLOGY, 2024, 34 (03) : 1982 - 1993
  • [9] MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy
    Pope, WB
    Lai, A
    Nghiemphu, P
    Mischel, P
    Cloughesy, TF
    NEUROLOGY, 2006, 66 (08) : 1258 - 1260
  • [10] MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy
    Chamberlain, Marc C.
    NEUROLOGY, 2006, 67 (11) : 2089 - 2089
12345